Partnering opportunity

Catalogue of non-exclusive intermediates to support pharmaceutical research offered under services agreement

Summary

A UK company has a catalogue of intermediates which can be used for the design & synthesis of novel compounds and offer a variety of customised commercial frameworks. They seeking partners to acquire these compounds and can supply them to researchers or companies in large amounts with a relatively short lead-time. They are seeking service or acquisition agreements with pharmaceutical or drug development companies/researchers interested in using these intermediates for new co-developed products.

Partner expertise sought

Not available

Description

The intermediates catalogue provides access to a wide variety of practical building blocks, many of which are unique to the company. The UK company supply all of these compounds in research quantities from stock, while the company's kilo lab facility offers many of these intermediates in 100g-1kg lots with lead times of only 4-6 weeks. In addition to the company's in-house developments, and in order to drive diversity and novelty in their customers' drug discovery programmes, the company fosters strategic collaborations that add new ranges to the intermediates catalogue. They are seeking pharmaceutical and drug development companies and/or researchers for acquisition agreements or services agreements, to supply these products to new partners and co-develop new intermediates with new clients. For example, a previous collaboration with a catalyst technology company resulted in the development of a series of spirodiamine compounds. Such spirodiamines have been shown to be useful in the construction of novel pharmaceutically relevant investigative compounds. The company also offers a variety of customised commercial frameworks, from simple fee-for-service right through to long-term FTE (full-time equivalent) projects. They are trusted by major pharma & biotech companies and operate an embedded team of FTE scientists inside the client's facility on a long-term basis. The company has a significant array of assets for small molecule discovery and has all the essential hardware for modern organic and computational chemistry, a purpose-built ADMET (absorption, distribution, metabolism, excretion and toxicity) lab with cell culture facilities, scale-up laboratories, automated purification to support array synthesis and a highly engineered suite for pressure chemistry. They are also available to offer their services towards any existing H2020 bids that might be relevant.

Advantages and innovations

The intermediates catalogue provides a large variety of practical building blocks, many of which are unique to the company. They can be supplied in research quantities from stock, while the kilo lab facility allows the company to offer many of these intermediates in 100g-1kg lots with lead times of 4-6 weeks. The company was founded in 1992 and is now considered a leading CRO (contract research organisation) in the UK. Using its heritage in the supply of rational building blocks for medicinal chemistry, biased screening libraries and custom synthesis as a springboard, the company now operates a comprehensive suite of services for hit-to-lead and lead optimisation studies. The company's workforce consists of over 85% PhD-level scientists, and the company has a purpose-built lab with cell culture facilities, scale-up laboratories with vessels up to 50L, automated purification to support array synthesis and a highly engineered suite for pressure chemistry.

Development stage

Not available

Intellectual Property Rights (IPR)

Not available


Register your interest

How it works

  • Tell us about yourself
  • We’ll discuss with you
  • We put the right partners in touch

EEN help you find the right partner, rather than you going it alone.

Our role is to review and collate the most suitable submissions, and then send them to the client who posted the opportunity. We consult with you, and the client, to make the process professional and easy.

These are live opportunities. Your registration of interest on the site is just like a professional approach to a business at a networking event. To stand the best chance of success, make your submission really sing. Sell why the client who posted the opportunity should work with you. Excite them. Ask questions. Try and avoid copy and pasting words from elsewhere.

Once the client has chosen their partner, we'll introduce them over email and keep in touch with both parties to see how it's going. Sometimes things progress quickly. Sometimes because of changing priorities for either party, things progress slowly, but you never know - your next big business break could start right here.

?What value does EEN add?
This is your pitch: remember to include your unique selling points (USP) and why someone would want to do business with you
Tell us why you are a good fit for this opportunity, and why you think you're the right people for this partnership
If there's anything additional, or commercially sensitive you'd like to know about this opportunity, please let us know

What next?

To finish up, we just need some extra details about you and your company